Publication | Open Access
Neurologic adverse events among 704,003 first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine in Mexico: A nationwide descriptive study
109
Citations
20
References
2021
Year
VaccinationVaccine SafetyVaccine DevelopmentVaccine SurveillanceVaccine EfficacyNeurologic Adverse EventsNationwide Descriptive StudyCovid-19 VaccineMedicineEpidemiologyCovid-19
| Year | Citations | |
|---|---|---|
Page 1
Page 1